Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elisa Annie Aquilanti, M.D.

Concepts (83)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Telomerase420247491.870 Why?
Glioblastoma5202434580.960 Why?
Brain Neoplasms7202290650.730 Why?
Glioma3202334910.550 Why?
Drug Discovery1202410650.530 Why?
Central Nervous System Neoplasms120249180.520 Why?
Enzyme Inhibitors2202437220.450 Why?
Telomere220249410.290 Why?
Gene Expression Regulation, Neoplastic2201886120.210 Why?
Lomustine12022600.200 Why?
Oligonucleotides120245610.190 Why?
Pathology, Molecular120233290.170 Why?
Cryoelectron Microscopy120246450.170 Why?
Promoter Regions, Genetic3202157840.170 Why?
Drug Design1202410400.160 Why?
Antineoplastic Agents, Alkylating120226140.150 Why?
Chromosomes, Human, Pair 1220186400.150 Why?
DNA Modification Methylases120182070.150 Why?
Neoplasms22024223440.150 Why?
Chromosomes, Human, Pair 19120183500.140 Why?
Tumor Burden1202318890.140 Why?
Mutation72024302090.140 Why?
DNA Repair Enzymes120183420.140 Why?
Immunotherapy2202447460.130 Why?
Lymphoma1202418960.120 Why?
Lung Neoplasms32024134830.100 Why?
Antineoplastic Agents32024136350.100 Why?
Isocitrate Dehydrogenase120189540.100 Why?
Medical Oncology1202323390.090 Why?
Genes, Essential120121850.090 Why?
Gene Deletion1201826670.090 Why?
Tumor Suppressor Proteins2201827950.090 Why?
Combined Modality Therapy1202285250.090 Why?
RNA-Binding Protein FUS12010770.090 Why?
Humans1320247661170.080 Why?
Neoplasm Metastasis1202048870.080 Why?
Prognosis22020299120.080 Why?
Sequence Deletion1201214940.070 Why?
DNA Methylation2201844250.060 Why?
RNA Splicing120109020.060 Why?
Neoplasm Recurrence, Local1202293780.060 Why?
Melanoma1202056950.050 Why?
Carcinoma, Non-Small-Cell Lung1202053880.050 Why?
Molecular Targeted Therapy1201228240.050 Why?
Matrix Metalloproteinase 13120201010.040 Why?
Amyotrophic Lateral Sclerosis1201014820.040 Why?
Genes, myc120203910.040 Why?
Mice, Nude1202036100.030 Why?
Phosphonoacetic Acid12012540.030 Why?
Phosphopyruvate Hydratase120121270.020 Why?
Cell Line22020155460.020 Why?
DNA Copy Number Variations1202020450.020 Why?
Adenovirus E1A Proteins12010810.020 Why?
HEK293 Cells1202042630.020 Why?
Hydroxamic Acids120124830.020 Why?
Polymorphism, Single Nucleotide12009160400.020 Why?
Neoplasm Transplantation1201220100.020 Why?
Cytoplasmic Granules120105730.020 Why?
Genes, Tumor Suppressor1201210600.020 Why?
Gene Knockdown Techniques1201216020.020 Why?
Protein Kinase Inhibitors1202456950.020 Why?
Homozygote1201217740.020 Why?
Nucleic Acid Hybridization1200913050.020 Why?
Loss of Heterozygosity120096630.020 Why?
Green Fluorescent Proteins1201020620.020 Why?
Genomics1202059260.010 Why?
Mice32020818390.010 Why?
DNA, Neoplasm1200917390.010 Why?
RNA, Small Interfering1201234240.010 Why?
Case-Control Studies12020222280.010 Why?
Recombinant Fusion Proteins1201037330.010 Why?
Reverse Transcriptase Polymerase Chain Reaction1200945650.010 Why?
Transcription Factors12020121300.010 Why?
Animals320201688000.010 Why?
Neoplasm Proteins1200935940.010 Why?
Cell Proliferation12012104330.010 Why?
Nerve Tissue Proteins1200943990.010 Why?
Cell Line, Tumor12012170710.010 Why?
DNA-Binding Proteins1201296010.010 Why?
Male120203639350.000 Why?
Female120203962330.000 Why?
Child12009805730.000 Why?
Adult120092231390.000 Why?
Aquilanti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (83)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.